Biotronik's Intica DX and Intica cardiac resynchronization therapy-DX implantable cardioverter defibrillators have been released in the US after receiving approval from the FDA. The devices feature technology that enables monitoring of atrial electrical activity without an atrial lead.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.